Advertising a drug’s name and a use that is off-label is “a double whammy,” said Patrick Massad, commissioner of the Pharmaceutical Advertising Advisory Board (PAAB), an organization that is ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

Senior Manager of Policy with Diabetes Canada, Laura O’Driscoll of Grand Falls-Windsor says when it comes to chronic illness like diabetes, an ounce of prevention is worth a pound of cure, and timely ...

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss ...

Donald Trump's latest pitch to voters ahead of critical midterm elections is that he's bringing drug prices down. But amid ...

Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result ...

Eli Lilly forecast 2026 profit above Wall Street estimates on Wednesday, as it expects strong demand for its blockbuster weight-loss and diabetes drugs, Zepbound and Mounjaro, to ...

One of Premier Susan Holt's campaign promises was to make contraception free by signing onto national pharmacare. Advocates ...